N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy

Journal of Neurochemistry

Volumn 112, Issue 1, 2010, Pages 77-91

  Kamboj, Sukhdev Singh ^a   Vasishta, Rakesh Kumar ^b   Sandhir, Rajat ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Apoptosis; Diabetic neuropathy; Hyperalgesia; N acetylcysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BIOCHEMICAL MARKER; CASPASE 3; CATALASE; CYTOCHROME C; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; PHOSPHOLIPID; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DIABETIC NEUROPATHY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERALGESIA; HYPERGLYCEMIA; LATENT PERIOD; LIPID PEROXIDATION; MALE; MOTOR COORDINATION; NERVE DEGENERATION; NERVE INJURY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCIATIC NERVE; TAIL FLICK TEST; TREADMILL; TREATMENT OUTCOME;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETIC NEUROPATHIES; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

ALLIUM CEPA; ANIMALIA; RATTUS; WALLERIA;

EID: 71649086882     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06435.x     Document Type: Article

References (139)

1. Aebi H. (1984) Catalase in vitro. Methods Enzymol. 105, 121 126.
2. Ahmed K., Matsuya Y., Nemoto H., Zaidi S. F., Sugiyama T., Yoshihisa Y., Shimizu T. Kondo T. (2009) Mechanism of apoptosis induced by a newly synthesized derivative of macrosphelides with a thiazole side chain. Chem. Biol. Interact. 177, 218 226.
3. Ali M. M. Agha F. G. (2009) Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand. J. Clin. Lab. Invest. 69, 371 379.
4. Apfel S. C., Asbury A. K., Bril V. et al. (2001) Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J. Neurol. Sci. 189, 3 5.
5. Arai K., Maguchi S., Fujii S., Ishibashi H., Oikawa K. Taniguchi N. (1987) Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites. J. Biol. Chem. 262, 16969 16972.
6. Arakawa M., Ushimaru N., Osada N., Oda T., Ishige K. Ito Y. (2006) N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death. Neurosci. Res. 55, 255 263.
7. Arora M., Kumar A., Kaundal R. K. Sharma S. S. (2008) Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy. Eur. J. Pharmacol. 596, 77 83.
8. Aruoma O. I., Halliwell B., Hoey B. M. Butler J. (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic. Biol. Med. 6, 593 597.
9. Aydin S., Ozaras R., Uzun H., Belce A., Uslu E., Tahan V., Altug T., Dumen E. Senturk H. (2002) N-acetylcysteine reduced the effect of ethanol on antioxidant system in rat plasma and brain tissue. Tohoku J. Exp. Med. 198, 71 77.
10. Baumgartner-Parzer S. M., Wagner L., Pettermann M., Grillari J., Gessl A. Waldhausl W. (1995) High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44, 1323 1327.
11. Beltowski J., Jamroz-Wisniewska A., Wojcicka G., Lowicka E. Wojtak A. (2008) Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension. Mol. Cell. Biochem. 319, 163 174.
12. Bianchi R., Buyukakilli B., Brines M. et al. (2004) Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc. Natl Acad. Sci. USA 101, 823 828.
13. Bierhaus A., Ziegler R. Nawroth P. P. (1998) Molecular mechanisms of diabetic angiopathy-sclues for innovative therapeutic interventions. Horm. Res. 50 (Suppl 1 1 5.
14. 2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. Brain Res. 1035, 86 93.
15. Bolajoko E. B., Mossanda K. S., Adeniyi F., Akinosun O., Fasanmade A. Moropane M. (2008) Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer. S. Afr. Med. J. 98, 614 617.
16. Bonnefont-Rousselot D. (2002) Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care 5, 561 568.
17. Calcutt N. A. Chaplan S. R. (1997) Spinal pharmacology of tactile allodynia in diabetic rats. Br. J. Pharmacol. 122, 1478 1482.
18. Calcutt N. A., Freshwater J. D. Mizisin A. P. (2004) Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47, 718 724.
19. Cameron N. E. Cotter M. A. (1995) Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J. Clin. Invest. 96, 1159 1163.
20. Cameron N. E. Cotter M. A. (1999) Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 45, 137 146.
21. Cameron N. E., Eaton S. E., Cotter M. A. Tesfaye S. (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44, 1973 1988.
22. Carlberg I. Mannervik B. (1985) Glutathione reductase. Methods Enzymol. 113, 484 490.
23. Cartmell S. M., Gelgor L. Mitchell D. (1991) A revised rotarod procedure for measuring the effect of antinociceptive drugs on motor function in the rat. J. Pharmacol. Methods 26, 149 159.
24. Ceriello A. (2006) Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr. Opin. Lipidol. 17, 510 518.
25. Chen T. Y., Chi K. H., Wang J. S., Chien C. L. Lin W. W. (2009) Reactive oxygen species are involved in FasL-induced caspase-independent cell death and inflammatory responses. Free Radic. Biol. Med. 46, 643 655.
26. Coppey L. J., Davidson E. P., Dunlap J. A., Lund D. D. Yorek M. A. (2000) Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int. J. Exp. Diabetes Res. 1, 131 143.
27. Coste T. C., Gerbi A., Vague P., Pieroni G. Raccah D. (2003) Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy. Diabetes 52, 2578 2585.
28. Courteix C., Eschalier A. Lavarenne J. (1993) Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53, 81 88.
29. Cui X. P., Li B. Y., Gao H. Q., Wei N., Wang W. L. Lu M. (2008) Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats. J. Nutr. Sci. Vitaminol. (Tokyo) 54, 321 328.
30. Cunha J. M., Jolivalt C. G., Ramos K. M., Gregory J. A., Calcutt N. A. Mizisin A. P. (2008) Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism 57, 873 881.
31. De Vries N. De Flora S. (1993) N-acetyl-l-cysteine. J. Cell. Biochem. Suppl. 17F, 270 277.
32. Dellon A. L. (2004) Diabetic neuropathy: review of a surgical approach to restore sensation, relieve pain, and prevent ulceration and amputation. Foot Ankle Int. 25, 749 755.
33. Demir S. Inal-Erden M. (1998) Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin. Chim. Acta 275, 127 135.
34. Du X., Stocklauser-Farber K. Rosen P. (1999) Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic. Biol. Med. 27, 752 763.
35. Edwards J. L., Vincent A. M., Cheng H. T. Feldman E. L. (2008) Diabetic neuropathy: mechanisms to management. Pharmacol. Ther. 120, 1 34.
36. Ferrari G., Yan C. Y. Greene L. A. (1995) N-acetylcysteine (D-and L-stereoisomers) prevents apoptotic death of neuronal cells. J. Neurosci. 15, 2857 2866.
37. Figueroa-Romero C., Sadidi M. Feldman E. L. (2008) Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev. Endocr. Metab. Disord. 9, 301 314.
38. Fiske C. H. Subbarow Y. (1925) The colorimetric determination of phosphorus. J. Biol. Chem. 66, 375 400.
39. Flohe L. Gunzler W. A. (1984) Assays of glutathione peroxidase. Methods Enzymol. 105, 114 121.
40. Folch J., Lees M. Sloane Stanley G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497 509.
41. Freshwater J. D., Svensson C. I., Malmberg A. B. Calcutt N. A. (2002) Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 51, 2249 2255.
42. Gul H., Yildiz O., Dogrul A., Yesilyurt O. Isimer A. (2000) The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain 89, 39 45.
43. Halliwell B. (1991) Drug antioxidant effects. A basis for drug selection? Drugs 42, 569 605.
44. Hancock J. T., Desikan R. Neill S. J. (2001) Does the redox status of cytochrome C act as a fail-safe mechanism in the regulation of programmed cell death? Free Radic. Biol. Med. 31, 697 703.
45. Hong S., Agresta L., Guo C. Wiley J. W. (2008) The TRPV1 receptor is associated with preferential stress in large dorsal root ganglion neurons in early diabetic sensory neuropathy. J. Neurochem. 105, 1212 1222.
46. Hounsom L. Tomlinson D. R. (1997) Does neuropathy develop in animal models? Clin. Neurosci. 4, 380 389.
47. Hung K. Y., Liu S. Y., Kao S. H., Huang J. W., Chiang C. K. Tsai T. J. (2009) N-acetylcysteine-mediated antioxidation prevents hyperglycemia-induced apoptosis and collagen synthesis in rat mesangial cells. Am. J. Nephrol. 29, 192 202.
48. Ido Y., McHowat J., Chang K. C., Arrigoni-Martelli E., Orfalian Z., Kilo C., Corr P. B. Williamson J. R. (1994) Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes 43, 1469 1477.
49. Ismael M. A., Talbot S., Carbonneau C. L., Beausejour C. M. Couture R. (2008) Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance. Eur. J. Pharmacol. 589, 66 72.
50. Jin H. Y., Joung S. J., Park J. H., Baek H. S. Park T. S. (2007) The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy. Diabet. Med. 24, 1034 1038.
51. Jolivalt C. G., Jiang Y., Freshwater J. D., Bartoszyk G. D. Calcutt N. A. (2006) Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. Diabetologia 49, 2775 2785.
52. Joseph E. K. Levine J. D. (2004) Caspase signalling in neuropathic and inflammatory pain in the rat. Eur. J. Neurosci. 20, 2896 2902.
53. Julius U., Drel V. R., Grassler J. Obrosova I. G. (2009) Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy. Exp. Clin. Endocrinol. Diabetes 117, 72 77.
54. Kamakura K., Ishiura S., Sugita H. Toyokura Y. (1983) Identification of Ca2+-activated neutral protease in the peripheral nerve and its effects on neurofilament degeneration. J. Neurochem. 40, 908 913.
55. Kamboj A., Kiran R. Sandhir R. (2006) Carbofuran-induced neurochemical and neurobehavioral alterations in rats: attenuation by N-acetylcysteine. Exp. Brain Res. 170, 567 575.
56. Kamboj S. S., Chopra K. Sandhir R. (2008a) Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes. Metab. Brain Dis. 23, 427 443.
57. Kamboj S. S., Kumar V., Kamboj A. Sandhir R. (2008b) Mitochondrial oxidative stress and dysfunction in rat brain induced by carbofuran exposure. Cell. Mol. Neurobiol. 28, 961 969.
58. Kamboj S. S., Chopra K. Sandhir R. (2009) Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of n-acetylcysteine supplementation. Neuroscience 162, 349 358.
59. Kamei J., Mizoguchi H., Narita M. Tseng L. F. (2001a) Therapeutic potential of PKC inhibitors in painful diabetic neuropathy. Expert Opin. Investig. Drugs 10, 1653 1664.
60. Kamei J., Zushida K., Morita K., Sasaki M. Tanaka S. (2001b) Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol. 422, 83 86. (Pubitemid 32595578)
61. Kamei J., Ohsawa M., Miyata S., Endo K. Hayakawa H. (2008) Effects of cytidine 5′-diphosphocholine (CDP-choline) on the thermal nociceptive threshold in streptozotocin-induced diabetic mice. Eur. J. Pharmacol. 598, 32 36.
62. Kim J., Rushovich E. H., Thomas T. P., Ueda T., Agranoff B. W. Greene D. A. (1991) Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes 40, 1545 1554.
63. Kim S. Y., Lee J. H., Yang E. S., Kil I. S. Park J. W. (2003) Human sensitive to apoptosis gene protein inhibits peroxynitrite-induced DNA damage. Biochem. Biophys. Res. Commun. 301, 671 674.
64. Kitatani K., Akiba S. Sato T. (2004) Ceramide-induced enhancement of secretory phospholipase A2 expression via generation of reactive oxygen species in tumor necrosis factor-alpha-stimulated mesangial cells. Cell. Signal. 16, 967 974.
65. van Klaveren R. J., Dinsdale D., Pype J. L., Demedts M. Nemery B. (1997) N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats. Am. J. Physiol. 273, L548 L555.
66. Kono Y. (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 186, 189 195.
67. Krishnan A. V., Lin C. S. Kiernan M. C. (2008) Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy. Brain 131, 1209 1216.
68. Kumar S. Sitasawad S. L. (2009) N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells. Life Sci. 84, 328 336.
69. Kumar S., Arun K. H., Kaul C. L. Sharma S. S. (2005) Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy. Neurol. Res. 27, 60 66.
70. Kumar G., Banu S. Murugesan A. G. (2009) Influence of Helicteres isora administration for diabetes mellitus: its effect on erythrocyte membrane and antioxidant status. Food Chem. Toxicol. 47, 1803 1809.
71. Kuzumoto Y., Kusunoki S., Kato N., Kihara M. Low P. A. (2006) Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat. Diabetologia 49, 3085 3093.
72. Lee J. W., Kim W. H., Lim J. H., Song E. H., Song J., Choi K. Y. Jung M. H. (2009) Mitochondrial dysfunction: glucokinase downregulation lowers interaction of glucokinase with mitochondria, resulting in apoptosis of pancreatic beta-cells. Cell. Signal. 21, 69 78.
73. Leinninger G. M., Backus C., Sastry A. M., Yi Y. B., Wang C. W. Feldman E. L. (2006) Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol. Dis. 23, 11 22.
74. Li Y., Feng Q., Arnold J. M. Peng T. (2009) Calpain activation contributes to hyperglycemia-induced apoptosis in cardiomyocytes. Cardiovasc. Res. 84, 100 110.
75. Lin X., Wang Y. J., Li Q., Hou Y. Y., Hong M. H., Cao Y. L., Chi Z. Q. Liu J. G. (2009) Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J. 276, 2022 2036.
76. Low P. A. Nickander K. K. (1991) Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40, 873 877.
77. Lowry O. H., Rosebrough N. J., Farr A. L. Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 275.
78. Mak D. H., Ip S. P., Li P. C., Poon M. K. Ko K. M. (1996) Alterations in tissue glutathione antioxidant system in streptozotocin-induced diabetic rats. Mol. Cell. Biochem. 162, 153 158.
79. Matsura T., Kai M., Fujii Y., Ito H. Yamada K. (1999) Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation. Free Radic. Res. 30, 73 83.
80. Mayer M. Noble M. (1994) N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc. Natl Acad. Sci. USA 91, 7496 7500.
81. McClare C. W. (1971) An accurate and convenient organic phosphorus assay. Anal. Biochem. 39, 527 530.
82. Melli G., Keswani S. C., Fischer A., Chen W. Hoke A. (2006) Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain 129, 1330 1338.
83. Miinea C., Kuruvilla R., Merrikh H. Eichberg J. (2002) Altered arachidonic acid biosynthesis and antioxidant protection mechanisms in Schwann cells grown in elevated glucose. J. Neurochem. 81, 1253 1262.
84. Moosmann B. Behl C. (2002) Antioxidants as treatment for neurodegenerative disorders. Expert Opin. Investig. Drugs 11, 1407 1435.
85. Naik A. K., Tandan S. K., Dudhgaonkar S. P., Jadhav S. H., Kataria M., Prakash V. R. Kumar D. (2006) Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. Eur. J. Pain 10, 573 579.
86. Nickander K. K., Schmelzer J. D., Rohwer D. A. Low P. A. (1994) Effect of alpha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J. Neurol. Sci. 126, 6 14.
87. Nickander K. K., McPhee B. R., Low P. A. Tritschler H. (1996) Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic. Biol. Med. 21, 631 639.
88. Ohkawa H., Ohishi N. Yagi K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351 358.
89. Ohsawa M. Kamei J. (1999) Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol. 372, 221 228.
90. Pacifici L., Bellucci A., Piovesan P., Maccari F., Gorio A. Ramacci M. T. (1992) Counteraction on experimentally induced diabetic neuropathy by levocarnitine acetyl. Int. J. Clin. Pharmacol. Res. 12, 231 236.
91. Paintlia M. K., Paintlia A. S., Singh A. K. Singh I. (2008) Attenuation of lipopolysaccharide-induced inflammatory response and phospholipids metabolism at the feto-maternal interface by N-acetyl cysteine. Pediatr. Res. 64, 334 339.
92. Paolisso G., Balbi V., Volpe C., Varricchio G., Gambardella A., Saccomanno F., Ammendola S., Varricchio M. D'Onofrio F. (1995) Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J. Am. Coll. Nutr. 14, 387 392.
93. Pop-Busui R., Marinescu V., Van Huysen C., Li F., Sullivan K., Greene D. A., Larkin D. Stevens M. J. (2002) Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. Diabetes 51, 2619 2628.
94. Preet A., Gupta B. L., Siddiqui M. R., Yadava P. K. Baquer N. Z. (2005) Restoration of ultrastructural and biochemical changes in alloxan-induced diabetic rat sciatic nerve on treatment with Na3VO4 and Trigonella-a promising antidiabetic agent. Mol. Cell. Biochem. 278, 21 31.
95. Quigley J. P. Gotterer G. S. (1969) Distribution of (Na+-K+)-stimulated ATPase activity in rat intestinal mucosa. Biochim. Biophys. Acta 173, 456 468.
96. Ratan R. R., Murphy T. H. Baraban J. M. (1994) Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J. Neurosci. 14, 4385 4392.
97. Reyes-Martin P., Ramirez-Rubio S., Parra-Cid T., Bienes-Martinez R. Lucio-Cazana J. (2008) 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism. Pharmacol. Res. 57, 344 350.
98. Roberts J. C. Francetic D. J. (1993) The importance of sample preparation and storage in glutathione analysis. Anal. Biochem. 211, 183 187.
99. Rothstein J. D., Bristol L. A., Hosler B., Brown Jr. R. H. Kuncl R. W. (1994) Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl Acad. Sci. USA 91, 4155 4159.
100. Rubino A., Rousculp M. D., Davis K., Wang J., Bastyr E. J. Tesfaye S. (2007) Diagnosis of diabetic peripheral neuropathy among patients with type 1 and type 2 diabetes in France, Italy, Spain, and the United Kingdom. Prim. Care Diabetes 1, 129 134.
101. Russell J. W., Sullivan K. A., Windebank A. J., Herrmann D. N. Feldman E. L. (1999) Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol. Dis. 6, 347 363.
102. Sagara M., Satoh J., Zhu X. P., Takahashi K., Fukuzawa M., Muto G., Muto Y. Toyota T. (1994) Inhibition with N-acetylcysteine of enhanced production of tumor necrosis factor in streptozotocin-induced diabetic rats. Clin. Immunol. Immunopathol. 71, 333 337.
103. Sagara M., Satoh J., Wada R., Yagihashi S., Takahashi K., Fukuzawa M., Muto G., Muto Y. Toyota T. (1996) Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia 39, 263 269.
104. Savelberg H. H., Schaper N. C., Willems P. J., de Lange T. L. Meijer K. (2009) Redistribution of joint moments is associated with changed plantar pressure in diabetic polyneuropathy. BMC Musculoskelet. Disord. 10, 16.
105. Scarpini E., Bianchi R., Moggio M., Sciacco M., Fiori M. G. Scarlato G. (1993) Decrease of nerve Na+,K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy. J. Neurol. Sci. 120, 159 167.
106. Sedlak J. L H. (1982) Changes of glutathione and protein bound SH-groups concentration in rat adrenals under acute and repeated stress. Endocrinol. Exp. 16, 103 109.
107. Sekido H., Suzuki T., Jomori T., Takeuchi M., Yabe-Nishimura C. Yagihashi S. (2004) Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells. Biochem. Biophys. Res. Commun. 320, 241 248.
108. Shelton R. J., Velavan P., Nikitin N. P., Coletta A. P., Clark A. L., Rigby A. S., Freemantle N. Cleland J. G. (2005) Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study. Eur. J. Heart Fail. 7, 127 135.
109. Siler-Marsiglio K. I., Shaw G. Heaton M. B. (2004) Pycnogenol and vitamin E inhibit ethanol-induced apoptosis in rat cerebellar granule cells. J. Neurobiol. 59, 261 271.
110. Sima A. A., Zhang W., Xu G., Sugimoto K., Guberski D. Yorek M. A. (2000) A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats. Diabetologia 43, 786 793.
111. Skalska S., Kyselova Z., Gajdosikova A., Karasu C., Stefek M. Stolc S. (2008) Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E. Gen. Physiol. Biophys. 27, 106 114.
112. Song M., Kellum J. A., Kaldas H. Fink M. P. (2004) Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J. Pharmacol. Exp. Ther. 308, 307 316.
113. Stevens M. J., Obrosova I., Cao X., Van Huysen C. Greene D. A. (2000) Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49, 1006 1015.
114. Sugimoto K., Murakawa Y. Sima A. A. (2000) Diabetic neuropathy-a continuing enigma. Diabetes Metab. Res. Rev. 16, 408 433.
115. Sugimoto K., Yasujima M. Yagihashi S. (2008) Role of advanced glycation end products in diabetic neuropathy. Curr. Pharm. Des. 14, 953 961.
116. Sweitzer S. M., Medicherla S., Almirez R., Dugar S., Chakravarty S., Shumilla J. A., Yeomans D. C. Protter A. A. (2004) Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model. Pain 109, 409 419.
117. Teixeira K. C., Soares F. S., Rocha L. G., Silveira P. C., Silva L. A., Valenca S. S., Dal Pizzol F., Streck E. L. Pinho R. A. (2008) Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. Pulm. Pharmacol. Ther. 21, 309 316.
118. Towbin H., Staehelin T. Gordon J. (1992) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 24, 145 149.
119. Ueno Y., Kizaki M., Nakagiri R., Kamiya T., Sumi H. Osawa T. (2002) Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J. Nutr. 132, 897 900.
120. Ulusu N. N., Sahilli M., Avci A. et al. (2003) Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Neurochem. Res. 28, 815 823.
121. Valensi P., Le Devehat C., Richard J. L., Farez C., Khodabandehlou T., Rosenbloom R. A. LeFante C. (2005) A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J. Diabetes Complications 19, 247 253.
122. Verhasselt V., Vanden Berghe W., Vanderheyde N., Willems F., Haegeman G. Goldman M. (1999) N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol. 162, 2569 2574.
123. Vettor R., Martini C., Calo L., Cantaro S., Macor C., De Palo C., Sicolo N., Scandellari C. Federspil G. (1992) Increased muscular phospholipase A2 activity in diabetic rats. Diabete Metab. 18, 213 217.
124. Viggiano A., Monda M., Viggiano D., Viggiano E., Chiefari M., Aurilio C. De Luca B. (2005) Trigeminal pain transmission requires reactive oxygen species production. Brain Res. 1050, 72 78.
125. Vincent A. M., Brownlee M. Russell J. W. (2002) Oxidative stress and programmed cell death in diabetic neuropathy. Ann. N Y Acad. Sci. 959, 368 383.
126. Vincent A. M., Perrone L., Sullivan K. A., Backus C., Sastry A. M., Lastoskie C. Feldman E. L. (2007) Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148, 548 558.
127. Warholm M., Guthenberg C., von Bahr C. Mannervik B. (1985) Glutathione transferases from human liver. Methods Enzymol. 113, 499 504.
128. Whitaker B. D. Knight J. W. (2008) Mechanisms of oxidative stress in porcine oocytes and the role of anti-oxidants. Reprod. Fertil. Dev. 20, 694 702.
129. Xia Z., Kuo K. H., Nagareddy P. R., Wang F., Guo Z., Guo T., Jiang J. McNeill J. H. (2007) N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc. Res. 73, 770 782.
130. Yan C. Y., Ferrari G. Greene L. A. (1995) N-acetylcysteine-promoted survival of PC12 cells is glutathione-independent but transcription-dependent. J. Biol. Chem. 270, 26827 26832.
131. Yu J., Zhang Y., Sun S., Shen J., Qiu J., Yin X., Yin H. Jiang S. (2006) Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can. J. Physiol. Pharmacol. 84, 579 587.
132. Yuan W. P., Liu B., Liu C. H., Wang X. J., Zhang M. S., Meng X. M. Xia X. K. (2009) Antioxidant activity of chito-oligosaccharides on pancreatic islet cells in streptozotocin-induced diabetes in rats. World J. Gastroenterol. 15, 1339 1345.
133. Zhang W., Kamiya H., Ekberg K., Wahren J. Sima A. A. (2007) C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. Diabetes Metab. Res. Rev. 23, 63 70.
134. Zherebitskaya E., Akude E., Smith D. R. Fernyhough P. (2009) Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 58, 1356 1364.
135. Zhu X. Eichberg J. (1990a) 1,2-diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J. Neurochem. 55, 1087 1090.
136. Zhu X. Eichberg J. (1990b) A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. Proc. Natl Acad. Sci. USA 87, 9818 9822.
137. Ziegler D., Nowak H., Kempler P., Vargha P. Low P. A. (2004) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet. Med. 21, 114 121. (Pubitemid 38221809)
138. Zochodne D. W. (2008) Diabetic polyneuropathy: an update. Curr. Opin. Neurol. 21, 527 533.
139. Zochodne D. W. Levy D. (2005) Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell. Mol. Biol. (Noisy-le-grand) 51, 255 267.